<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><submitter>Oswell CS</submitter><funding>NIDA NIH HHS</funding><funding>NINDS NIH HHS</funding><funding>NIGMS NIH HHS</funding><pubmed_abstract>The anterior cingulate cortex is a key brain region involved in the affective and motivational dimensions of pain, yet how opioid analgesics modulate this cortical circuit remains unclear. Uncovering how opioids alter nociceptive neural dynamics to produce pain relief is essential for developing safer and more targeted treatments for chronic pain. Here we show that a population of cingulate neurons encodes spontaneous pain-related behaviors and is selectively modulated by morphine. Using deep-learning behavioral analyses combined with longitudinal neural recordings in mice, we identified a persistent shift in cortical activity patterns following nerve injury that reflects the emergence of an unpleasant, affective chronic pain state. Morphine reversed these neuropathic neural dynamics and reduced affective-motivational behaviors without altering sensory detection or reflexive responses, mirroring how opioids alleviate pain unpleasantness in humans. Leveraging these findings, we built a biologically inspired gene therapy that targets opioid-sensitive neurons in the cingulate using a synthetic mu-opioid receptor promoter to drive chemogenetic inhibition. This opioid-mimetic gene therapy recapitulated the analgesic effects of morphine during chronic neuropathic pain, thereby offering a new strategy for precision pain management targeting a key nociceptive cortical opioid circuit with safe, on-demand analgesia.</pubmed_abstract><journal>bioRxiv : the preprint server for biology</journal><pagination>2024.04.26.591113</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11092437</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Mimicking opioid analgesia in cortical pain circuits.</pubmed_title><pmcid>PMC11092437</pmcid><funding_grant_id>T32 DA028874</funding_grant_id><funding_grant_id>F32 DA053099</funding_grant_id><funding_grant_id>F32 DA055458</funding_grant_id><funding_grant_id>R00 DA043609</funding_grant_id><funding_grant_id>R21 DA055846</funding_grant_id><funding_grant_id>F31 DA057795</funding_grant_id><funding_grant_id>R34 DA059509</funding_grant_id><funding_grant_id>R01 DA056599</funding_grant_id><funding_grant_id>RF1 NS126073</funding_grant_id><funding_grant_id>DP2 GM140923</funding_grant_id><funding_grant_id>R01 NS130044</funding_grant_id><funding_grant_id>F31 NS125927</funding_grant_id><funding_grant_id>R01 DA054374</funding_grant_id><funding_grant_id>F31 DA062445</funding_grant_id><pubmed_authors>Beier KT</pubmed_authors><pubmed_authors>Banghart MR</pubmed_authors><pubmed_authors>Wachira M</pubmed_authors><pubmed_authors>Creasy KT</pubmed_authors><pubmed_authors>Vasquez JJ</pubmed_authors><pubmed_authors>Wojick JA</pubmed_authors><pubmed_authors>Ortega RAS</pubmed_authors><pubmed_authors>Beattie K</pubmed_authors><pubmed_authors>Farinas SA</pubmed_authors><pubmed_authors>Wu JK</pubmed_authors><pubmed_authors>Wooldridge LM</pubmed_authors><pubmed_authors>Jo A</pubmed_authors><pubmed_authors>Deisseroth K</pubmed_authors><pubmed_authors>Mahmood M</pubmed_authors><pubmed_authors>Ramakrishnan C</pubmed_authors><pubmed_authors>Yttri EA</pubmed_authors><pubmed_authors>Corder G</pubmed_authors><pubmed_authors>Lo E</pubmed_authors><pubmed_authors>James JG</pubmed_authors><pubmed_authors>Azouz G</pubmed_authors><pubmed_authors>Reiner BC</pubmed_authors><pubmed_authors>Rogers SA</pubmed_authors><pubmed_authors>Rodrigues A</pubmed_authors><pubmed_authors>Oswell CS</pubmed_authors><pubmed_authors>Hsu AI</pubmed_authors><pubmed_authors>Ejoh LL</pubmed_authors><pubmed_authors>Salimando GJ</pubmed_authors><pubmed_authors>Kimmey BA</pubmed_authors><pubmed_authors>Crist RC</pubmed_authors><pubmed_authors>McCall NM</pubmed_authors><pubmed_authors>Chehimi SN</pubmed_authors></additional><is_claimable>false</is_claimable><name>Mimicking opioid analgesia in cortical pain circuits.</name><description>The anterior cingulate cortex is a key brain region involved in the affective and motivational dimensions of pain, yet how opioid analgesics modulate this cortical circuit remains unclear. Uncovering how opioids alter nociceptive neural dynamics to produce pain relief is essential for developing safer and more targeted treatments for chronic pain. Here we show that a population of cingulate neurons encodes spontaneous pain-related behaviors and is selectively modulated by morphine. Using deep-learning behavioral analyses combined with longitudinal neural recordings in mice, we identified a persistent shift in cortical activity patterns following nerve injury that reflects the emergence of an unpleasant, affective chronic pain state. Morphine reversed these neuropathic neural dynamics and reduced affective-motivational behaviors without altering sensory detection or reflexive responses, mirroring how opioids alleviate pain unpleasantness in humans. Leveraging these findings, we built a biologically inspired gene therapy that targets opioid-sensitive neurons in the cingulate using a synthetic mu-opioid receptor promoter to drive chemogenetic inhibition. This opioid-mimetic gene therapy recapitulated the analgesic effects of morphine during chronic neuropathic pain, thereby offering a new strategy for precision pain management targeting a key nociceptive cortical opioid circuit with safe, on-demand analgesia.</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Apr</publication><modification>2026-06-22T03:15:38.072Z</modification><creation>2026-06-22T03:08:08.866Z</creation></dates><accession>S-EPMC11092437</accession><cross_references><pubmed>38746090</pubmed><doi>10.1101/2024.04.26.591113</doi></cross_references></HashMap>